Hebrew SeniorLife, based in Boston, and Brown University in Providence have received a federal grant of $53.4m that could provide improved quality of life and healthcare for those with Alzheimer’s disease.
Announcements of such awards can be made known to the public through poster printing.
The award from the National Institute on Aging will support a research incubator, which will look at non-drug interventions as opposed to other research on Alzheimer’s that investigates pharmaceuticals. Researchers from Fall River and other scientists from across the country will be involved in this research.
Brown University said that the objective of the grant is to support 40 pilot drug trials testing care-based interventions to help people who have dementia. The other is to develop best practices for evaluating such interventions and being able to share them with the rest of the research community.
President Christina Paxson commented that scholars from Brown, Hebrew SeniorLife, and others will be able to collaborate in making a positive impact in the treatment of this disease.
President and CEO of Hebrew SeniorLife, Louis Wolf, added that the same level of investment and focus on research should be given to Alzheimer’s and other dementias as for cancer. He expressed his pride in being able to work with Brown University to address this disease, which affects not only the patients but their caregivers and families as well.
